These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 35378133)
1. Long noncoding RNA ELDR promotes cell cycle progression in normal oral keratinocytes through induction of a CTCF-FOXM1-AURKA signaling axis. Sur S; Steele R; Ko BCB; Zhang J; Ray RB J Biol Chem; 2022 May; 298(5):101895. PubMed ID: 35378133 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA ELDR enhances oral cancer growth by promoting ILF3-cyclin E1 signaling. Sur S; Nakanishi H; Steele R; Zhang D; Varvares MA; Ray RB EMBO Rep; 2020 Dec; 21(12):e51042. PubMed ID: 33043604 [TBL] [Abstract][Full Text] [Related]
3. Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors. Mancini M; De Santis S; Monaldi C; Bavaro L; Martelli M; Castagnetti F; Gugliotta G; Rosti G; Santucci MA; Martinelli G; Cavo M; Soverini S J Exp Clin Cancer Res; 2019 May; 38(1):216. PubMed ID: 31122263 [TBL] [Abstract][Full Text] [Related]
4. Emerging role of lncRNA ELDR in development and cancer. Sur S; Ray RB FEBS J; 2022 Jun; 289(11):3011-3023. PubMed ID: 33860640 [TBL] [Abstract][Full Text] [Related]
5. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma. Zhang B; Zhang Y; Zou X; Chan AW; Zhang R; Lee TK; Liu H; Lau EY; Ho NP; Lai PB; Cheung YS; To KF; Wong HK; Choy KW; Keng VW; Chow LM; Chan KK; Cheng AS; Ko BC J Pathol; 2017 Dec; 243(4):418-430. PubMed ID: 28862757 [TBL] [Abstract][Full Text] [Related]
6. FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells. Yang N; Wang C; Wang Z; Zona S; Lin SX; Wang X; Yan M; Zheng FM; Li SS; Xu B; Bella L; Yong JS; Lam EW; Liu Q Oncogene; 2017 Jun; 36(24):3428-3440. PubMed ID: 28114286 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of lncRNA Fujii Y; Amatya VJ; Kushitani K; Suzuki R; Kai Y; Kambara T; Takeshima Y Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34859258 [TBL] [Abstract][Full Text] [Related]
8. AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy. Puig-Butille JA; Vinyals A; Ferreres JR; Aguilera P; Cabré E; Tell-Martí G; Marcoval J; Mateo F; Palomero L; Badenas C; Piulats JM; Malvehy J; Pujana MA; Puig S; Fabra À J Invest Dermatol; 2017 Jun; 137(6):1297-1310. PubMed ID: 28188776 [TBL] [Abstract][Full Text] [Related]
9. A new tandem repeat-enriched lncRNA XLOC_008672 promotes gastric carcinogenesis by regulating G3BP1 expression. Li L; Yu S; Dou N; Wang X; Gao Y; Li Y Cancer Sci; 2024 Jun; 115(6):1851-1865. PubMed ID: 38581120 [TBL] [Abstract][Full Text] [Related]
10. FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells. Takeshita H; Yoshida R; Inoue J; Ishikawa K; Shinohara K; Hirayama M; Oyama T; Kubo R; Yamana K; Nagao Y; Gohara S; Sakata J; Nakashima H; Matsuoka Y; Nakamoto M; Hirayama M; Kawahara K; Takahashi N; Hirosue A; Kuwahara Y; Fukumoto M; Toya R; Murakami R; Nakayama H Lab Invest; 2023 May; 103(5):100060. PubMed ID: 36801643 [TBL] [Abstract][Full Text] [Related]
11. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia. Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107 [TBL] [Abstract][Full Text] [Related]
12. Induction of cancer cell stemness in glioma through glycolysis and the long noncoding RNA HULC-activated FOXM1/AGR2/HIF-1α axis. Li YP; Liu Y; Xiao LM; Chen LK; Tao EX; Zeng EM; Xu CH Lab Invest; 2022 Jul; 102(7):691-701. PubMed ID: 35013529 [TBL] [Abstract][Full Text] [Related]
13. EPS8 upregulates FOXM1 expression, enhancing cell growth and motility. Wang H; Teh MT; Ji Y; Patel V; Firouzabadian S; Patel AA; Gutkind JS; Yeudall WA Carcinogenesis; 2010 Jun; 31(6):1132-41. PubMed ID: 20351091 [TBL] [Abstract][Full Text] [Related]
14. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1. Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782 [TBL] [Abstract][Full Text] [Related]
15. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells. Hamurcu Z; Ashour A; Kahraman N; Ozpolat B Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606 [TBL] [Abstract][Full Text] [Related]
16. Aurora kinase A stabilizes FOXM1 to enhance paclitaxel resistance in triple-negative breast cancer. Yang N; Wang C; Wang J; Wang Z; Huang D; Yan M; Kamran M; Liu Q; Xu B J Cell Mol Med; 2019 Sep; 23(9):6442-6453. PubMed ID: 31359594 [TBL] [Abstract][Full Text] [Related]
17. Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF. Zhao X; Li D; Huang D; Song H; Mei H; Fang E; Wang X; Yang F; Zheng L; Huang K; Tong Q Mol Ther; 2018 Mar; 26(3):755-773. PubMed ID: 29398485 [TBL] [Abstract][Full Text] [Related]
18. FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway. Meng H; Zhao B; Wang Y Exp Mol Pathol; 2020 Aug; 115():104451. PubMed ID: 32417392 [TBL] [Abstract][Full Text] [Related]
19. LncRNA SBF2-AS1 inhibits apoptosis and promotes proliferation in lung cancer cell via regulating FOXM1. Qi H; Wang L; Zhang X; Sun W; Liu J J BUON; 2020; 25(4):1761-1770. PubMed ID: 33099911 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway. Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]